30 Day Trial

Sanofi Viscosupplement Growth in Emerging Markets Offsets U.S. Losses

Share:

Sanofi reports 3Q19 Synvisc revenue of €73MM (USD $82MM), +1.4% vs. 3Q18.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.